We will have to leave it at that. We do have to vote on supplementary estimates.
Mr. Vermaeten, there may be a big debate between different parties and different members on how we got here, but I think you can see from every member, including me, that there's a huge concern over the type 1 diabetes approval and disapproval. I want to outline to you that sometimes there's lobbying by an organization, but I can tell you on my own part that it isn't just Diabetes Canada that we hear from; it's individuals on the ground in all our ridings. I'd just ask you as assistant commissioner to keep that in mind in your deliberations, and we hope the advisory committee will help in that regard.
Our thanks to all three of you for your appearance and for answering questions.
Committee members, we need to vote on supplementary estimates (B). You have them before for you.
CANADA REVENUE AGENCY Vote 1b—Operating expenditures..........$44,941,394
(Vote 1b agreed to)
Shall I report the supplementary estimates (B), 2017-18, under Canada Revenue Agency, to the House?